Recent Posts

Novartis’s new CEO has cash, momentum for an overhaul

Asset swaps have been a big thing in pharma over the past few years. Now it’s time for the un-swap. Novartis AG said it was unwinding part of a complicated 2014 asset swap with GlaxoSmithKline PLC, trading its stake in their consumer-health joint venture for $13 billion. The decision isn’t a huge surprise, though the timing is unexpected. It suggests ...

Read More »

These trade jabs don’t look like economic warfare

So is a trade war upon us? President Donald Trump announced last week that the US would place $60 billion worth of tariffs on Chinese goods, but what does that mean for the future of world trade? This conflict seems more likely to remain a modest spat than to blossom into a slugfest. First of all, China responded to Trump’s ...

Read More »

Uber can’t afford to be an ugly American abroad

Anybody who commutes via ride-share in one of Southeast Asia’s traffic-choked cities knows that Uber Technologies Inc. has always been an also-ran in the fast-growing region. Compared with Grab Taxi Holdings Pte. Ltd., the dominant ride-sharing company in Southeast Asia, it consistently had fewer cars available and was perpetually behind in offering localized services. When Uber announced on Monday that ...

Read More »
Send this to a friend